Business
Futura Medical Announces Investor Seminar
Futura Medical Announces Investor Seminar.
About this update from Futura Medical Plc
[{"type":"text","content":"\n\n \n \n8 June 2023\n \n Futura Medical plc\n(\"Futura\" or the \"Company\")\nFutura Medical Announces Investor Seminar\n \nFutura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, is pleased to announce that it will be hosting an Investor Seminar on the 22 June 2023 in London for analysts and institutional investors. Following the Investor Seminar, an Investor Meet Company meeting will be held for Retail Investors on Monday the 26 June.\n \nThe Investor Seminar follows a milestone year to date following the UK launch on the 18 April 2023 of MED3000 under the brand name Eroxon® with Cooper Consumer Health, its EU and UK distribution partner, and online launches in Europe and in retail pharmacies in Belgium.\n \nThe Investor Sseminar will feature presentations from Futura as well as eminent Key Opinion Leaders (KOLs) Dr Jeff Foster, BSc, (Hons), MB ChB, DRCOG, MRCGP, men's health specialist and book author and Dr Janine David, FECSM, GP who specialises in Men and Women's sexual health and will close with a presentation by Mark Berkhout, International Marketing Director for Cooper Consumer Health & Jon Connolly Marketing Director Ceuta Healthcare\n \nFor further information on the Investor Seminar, or to register your interest, please contact Optimum Strategic Communications at [email protected]. Further information will be made available closer to the event.\n \nA recording will be made available through a webcast which can be accessed via the investor section of the Futura website shortly after the event. No new material disclosures will be made at the event.\n \nThe Retail Investor event is scheduled for Monday 26 June at 10:00am with Investor Meet Company. Retail Investors can sign up to Investor Meet Company for free via www.investormeetcompany.com.\n \n-ENDS-\n \nFor further information, please contact:\n \nFutura Medical plc\nJames Barder, Chief Executive Officer\nAngela Hildreth, Finance Director and COO\nEmail: [email protected]\nTel: +44 (0) 1483 685 670\nwww.futuramedical.com\n \nNominated Adviser and Sole Broker:\n \nLiberum\nPhil Walker/...